Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
<h4>Objective</h4>To clarify whether antiparkinsonian drugs contribute to nocturnal sleep disturbances in patients with Parkinson's disease (PD).<h4>Background</h4>Although the major antiparkinsonian drugs L-dopa and dopamine agonists (DAs) have been found to affect slee...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e8ffd43dcce34cb4b784d0d96a8bc379 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|